Successful immunization against experimental allergic encephalomyelitis with myelin basic protein-sensitized allogeneic lymphocytes

Neurochemical Research - Tập 6 - Trang 699-718 - 1981
George A. Hashim1
1The Jane Forbes Clark Surgical Research Laboratories Department of Surgery and Microbiology, St. Luke's-Roosevelt Hospital Center and Columbia University, New York

Tóm tắt

Prevention and suppression of experimental allergic encephalomyelitis were demonstrated in rats, guinea pigs, and rabbits immunized with allogeneic, but not with syngeneic lymphocytes from susceptible donors sensitized to myelin basic protein (MBP). Donor lymphnode, splenic, or peripheral blood lymphocytes were effective in inducing a state of unresponsiveness to an encephalitogenic challenge in either of the three species. Unresponsiveness was not obtained in recipients immunized with sensitized allogenic lymphocytes and simulatenously challenged with MBP suggesting that a time lapse between immunization and challenge is necessary for the development of protective immunity. Induced in immunized recipients, unresponsiveness was transferred into normal syngeneic recipients with immunoglobulin-G (IgG) isolated from protected donors before challenge. Furthermore, both immunized and IgG recipients failed to develop cell-mediated immunity after challenge with MBP. The results show that prevention and suppression of EAE was mediated by antibodies which inhibited the development of delayed type hypersensitivity to the challenging antigen.

Tài liệu tham khảo

Hughes, R. C. 1976. Membrane Glycoproteins, Butterworths London-Boston. Nicolson, G. L., Robbins, J. C., andHyman, R. 1976. Cell surface receptors and their dynamics on toxin-treated malignant cells. Pages 15–26,in Nicolson, G. L., Raftery, M. A., Rodbell, M., andFox, C. F. (eds.), Progress in clinical and biological research, Vol. 8, Liss, New York. Cantor, H., andGershan, R. K. 1980. Pages 15–36,in Pernis, B., andVogel, H. J. (eds.), Regulatory T lymphocytes, Academic Press, New York. Benacerraf, B. 1980. Regulatory T lymphocytes and their antigen receptors. Pages 3–11,in Pernis, B., andVogel, H. J. (eds.), Regulatory T lymphocytes, Academic Press, New York. Hashim, G. A., Lea, D. H., andPierce, J. C. 1977. Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis. Neurochem. Res. 2:99–109. Hashim, G. A., andSharpe, R. D. 1974. Experimental allergic encephalomyelitis: The structural specificity of determinants for delayed hypersensitivity. Immunochem. 11:633–640. Paterson, P. Y. 1960. Transfer of experimental allergic encephalomyelitis by means of lymphnode cells. J. Exp. Med. 111:119–136. Levine, S., Hoenig, E. M., andKies, M. W. 1970. Allergice encephalomyelitis: Immunologically specific inhibition of cellular passive transfer by encephalitogenic basic protein. Clin. Exp. Immunol. 6:503–517. Hashim, G. A. 1981. Experimental allergic encephalomyelitis: Activation of suppressor T lymphocytes by a modified sequence of the T effector determinant. J. Immunol. 126:419–423. Kardys, E., andHashim, G. A. 1981. Experimental allergic encephalomyelitis in Lewis rats: Immunogregulation of disease by a single amino acid substitution in the disease-inducing determinant. J. Immunol. (submitted). Paterson, P. Y., andHarwin, S. M. 1963. Suppression of allergic encephalomyelitis in rats by means of antibrain serum. J. Exp. Med. 117:755–774. Hashim, G. A., Sharpe, R. D., Carvalho, E., andStevens, L. E. 1975. The development of experimental allergic encephalomyelitis with immunizing doses of myelin basic protein. Proc. Soc. Exp. Biol and Med. 149:646–651. Lennon, V., Wittingham, S., Carnegie, P. R., McPherson, J. A., andMackay, I. R. 1971. Detection of antibodies to the basic protein from myelin by radioimmunoassay and immunofluorescence. J. Immunol. 107:56–62. Day, E. D., andPitts, O. M. 1974. The antibody response to myelin basic protein in Lewis rats: The effect of time, dosage of basic protein and dosage of mycobacterium butyricum. J. Immunol. 113:1958–1962. Eylar, E. H., Salk, J., Beveridge, G. C., andBrown, L. V. 1969. Experimental allergic encephalomyelitis: Basic protein from bovine myelin. Anch. Biochem. Biophys. 132:34–48. Hashim, G. A., Hwang, F., andSchilling, F. J. 1973. Experimental allergic encephalonyelitis: Basic protein regions responsible for delayed hypersensitivity. Ach. Biochem. Biophys. 156:298–309. Stone, S. H., Lerner, E. M., II, andGoode, J. H. 1968. Adoptive Autoimmune encephalitis in inbred guinea pigs: Immunological and histological aspects. Science 159:995–996. Hashim, G. A., Sharpe, R. D., andCarvalho, E. F. 1979. Experimental allergic encephalomyelitis: Sequestered encephalitogenic determinant in the bovine myelin basic protein. J. Neurochem. 32:73–77. Williams, R. M., andMoore, M. J. 1973. Linkage of susceptibility of experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J. Exp. Med. 138:775–783. McFarlin, D. E., Hsu, S. C-L., Slemenda, S. B., Chou, F. C-H., andKibler, R. F. 1975. The immune response against myelin basic protein in two strains of rats with different genetic capacity to develop experimental allergic encephalomyelitis. J. Exp. Med. 141:72–81. Gasser, D. L., Palm, J., andGonatas, N. K. 1975. Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats. J. Immunol. 115:431–433. Levine, S., andSowinski, R. 1975. Allergic encephalomyelitis in the reputedly resistant brown norway strain of rats. J. Immunol. 114:597–601. Bell, J., andPaterson, P. Y. 1960. Rapid induction of allergic encephalomyelitis in rats without the use of mycobacteria. Science 131:1448–1451. Freund, J. 1957. Sensitization with organ-specific antigens and the mechanism of enhancement of the immune responses. J. Allergy 28:18–22. Hashim, G. A. 1980. Failure of myelin basic protein to prevent or suppress experimental allergic encephalomyelitis in guinea pigs. Neurochem. Res. 5:101–113. Lumsden, C. F. 1949. Experimental “allergic” encephalomyelitis: on the nature of encephalogenic agent. Brain 72:517–537. Kies, M. W., andAlvord, E. C., Jr. 1958. Prevention of allergic encephalomyelitis by prior injection of adjuvant. Nature 182:1106–1107. Benacerraf, B., andMcDevitt, H. O. 1972. The histocompatibility linked immune response genes. Science 175:273–274. Flax, M. H., andWaksman, B. H. 1962. Delayed cutaneous reactions in the rat. J. Immunol. 89:496–504. Flax, M. H., andWaksman, B. H. 1963. Further Immunologic studies of adjuvant disease in the rat. Int. Arch. Allergy 23:331–347. Alvord, E. C., Jr. 1970. Acute disseminated encephalomyelitis and allergic neuroencephalopathies. Pages 500–571,in Vinken, P. J., andBruyn, G. W. (eds.), Handbook of clinical neurology, Vol. 9, North Holland Publishing, Amsterdam. Robez-Einstein, E., andHenderson, N. 1959. Preparation and properties of water soluble proteins from bovine cord with allergic encephalomyelitic activity. Pages 287–292,in Kifs, M. W., andAlvord, E. C., Jr. (eds.), Allergic encephalomyelitis, Charles C Thomas Publishers, Springfield, Illinois. Benacerraf, B. 1976. Interrelationships between products of the major histocompatibility complex and their relevance to disease.in Katz, D. H., andBenacerraf, B. (eds.), The role of products of the histocompatibility gene complex in immune response, Academic Press, New York.